WHWK · Whitehawk Therapeutics Inc
United States · RS rating 34 · As of 2026-11-03
| Price | 3.10 USD |
|---|---|
| 1-day change | -0.6% |
| RS rating (overall / 1M / 3M / 12M) | 34 / 26 / 27 / 75 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 29 / 32 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -30.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +39.2% |
| Market cap (USD) | $196.8M |